|
|
||||||||
J Thorac Cardiovasc Surg 2006;132:1156-1161
© 2006 The American Association for Thoracic Surgery
Evolving Technology |
a Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
b Faculty of Science, University of Alberta, Edmonton, Alberta, Canada
c Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
* Address for reprints: Eric J. Lehr, MD, Department of Surgery, University of Alberta Hospital, Dvorkin Lounge, 8440 112th St, Edmonton, AB, Canada T6G 2B7. (Email: elehr{at}ualberta.ca).
| Abstract |
|---|
|
|
|---|
METHODS: Functional allogenicity was assessed by standard one-way mixed lymphocyte reaction assay using peripheral blood mononuclear cells. Responder cells were stimulated with irradiated stimulator cells and cultured at 37°C in 95% air and 5% carbon dioxide for 3, 4, 5, and 6 days. Cultures were pulsed with tritiated thymidine for 24 hours and harvested onto filtermats.
RESULTS: The allogeneic response, measured as counts per minute, demonstrated a bimodal distribution. Fifty-nine (36.9%) of 160 pairs fell within the first peak (counts per minute < 10,000) and were defined as weak responders. The remaining 101 (63.1%) of 160 pairs of animals demonstrated a strong allogeneic response (counts per minute
10,000) that followed a normal distribution.
CONCLUSIONS: More than 1 in 3 pairs of sheep is too closely related to elicit an immune response when cross-reacted. This finding may alter the interpretation of studies that base their findings on allogeneic transplantations in sheep without ascertaining the genetic similarities of the animals. Valve transplantation studies in a sheep model should assess the extent of allogenicity of donor and recipient sheep.
| Introduction |
|---|
|
|
|---|
|
Cryopreserved allograft cardiovascular tissue elicits a strong cellular and humoral1-3
immune response in recipients. When it is used to correct congenital heart defects in children, the host immune response may accelerate the deterioration of the allograft,4
resulting in reduced freedom from reoperation,5
and may complicate future heart transplantation.6,7
Increasing data suggest that decellularizing the allograft may attenuate the host's immune response.8
Inbred rodent models have been valuable in characterizing the alloreactive immune response against cryopreserved cardiovascular tissue8,9
; however, preclinical work requires the use of large-animal models to confirm the immunologic findings in large animals and to assess safety of the valve or tissue. The US Food and Drug Administration highly suggests testing cardiovascular tissue in sheep,10
which are comparable in size to humans and provide an accelerated model of calcification.11
Accordingly, there are several reports considering the effect of decellularization on the alloresponse.12,13
These studies assume allogenicity of the animals but do not assess the degree of inbreeding between donor and recipient animals. Unlike rat and mouse models, sheep used for animal studies are taken from flocks raised for human consumption. Although many farmers attempt to minimize inbreeding, the level of allogenicity within flocks has not been described. Furthermore, there are no well-characterized flocks of inbred sheep available to ensure allogenicity between donors and recipients. We therefore sought to determine the level of inbreeding within a flock of local farm sheep.
Because the ovine major histocompatibility complex (MHC) is incompletely characterized, we chose to perform a functional assay. The alloresponsiveness of MHC antigens between potential transplant donors and recipients can be assessed by in vitro mixed lymphocyte reaction (MLR) assay. MLR primarily reflects the allogeneic immune response against class II donor-specific antigens. Although genotyping has replaced functional assays for tissue-typing donors and recipients in clinical organ transplantation, MLR has been recently shown to predict patients who are at high risk for graft failure and may be used as an adjunct to DNA methods.14
In addition, MLR reactivity may be disparate with results obtained by serologic typing.15
MLR remains a viable method of assessing allogenicity. Therefore, we used 1-way MLR assay to study the alloresponsiveness within a group of 19 juvenile sheep.
| Materials and Methods |
|---|
|
|
|---|
Animal Husbandry
Suffolk sheep were obtained from a local farm that raises approximately 1800 food-quality lambs per year from 1000 ewes and 50 rams. To minimize inbreeding, the rams and ewes are divided into 3 groups. Over 3 years, each group of rams is rotated through each group of ewes. Every year, 5 to 6 rams from each group are replaced with rams obtained from various farms across Alberta. Offspring are never bred with their parents or siblings.
Cell Collection
Blood was collected from the jugular vein of each sheep and transported at room temperature. Peripheral blood mononuclear cells (PBMCs) were isolated by mixing equal portions of blood and 0.9% saline (Baxter, Toronto, Ontario, Canada), overlaying on 15 mL of Lympholyte Mammal density gradient (Cedarlane, Hornby, Ontario, Canada) and centrifuging for 45 minutes at 2200 rpm at room temperature. The layer of PBMCs was carefully aspirated, and the contaminating red blood cells were lysed with red blood cell lysis buffer (pH 7.3). PBMCs were washed twice in 0.9% saline, and stimulator PBMCs were frozen at a concentration of 2.5 x 107/mL in 10% dimethyl sulfoxide and fetal bovine serum at 80°C until needed. Responder cells were used immediately upon isolation.
One-way MLR
Alloresponsiveness between sheep was tested by using 1-way MLR assay as previously described.17
Briefly, stimulator cells were thawed in 40 mL of Hanks balanced salt solution (Invitrogen, Burlington, Ontario, Canada) supplemented with 5% fetal bovine serum and 1 mg/L deoxyribonuclease (Roche, Laval, Quebec, Canada) and then incubated at 37°C for 40 minutes. PBMCs were suspended in 10 mL of Hanks balanced salt solution and irradiated with 2500 rads on a cobalt 60 irradiator (MDS Nordion, Vancouver, Canada). After irradiation, cells were washed in Hanks balanced salt solution and suspended in Eagle modified essential medium supplemented with 10% fetal bovine serum, 1.0 x 105 mol/L 2-mercaptoethanol, and 1% penicillin-streptomycin (Sigma, Oakville, Ontario, Canada). Responder cells were harvested on the day of experimentation, isolated as described previously, and suspended in supplemented Eagle modified essential medium.
Stimulator cells (3.0 x 105) and responder cells (5.0 x 105) were cocultured in 96-well flat-bottom tissue culturetreated plates (Falcon, Franklin Lakes, NJ) in a total volume of 0.2 mL per well. Positive controls consisted of responder cells treated with 0.1 g/L concanavalin A (Sigma), and negative controls consisted of stimulator and responder cells alone, as well as double-irradiated stimulator and responder cultures. Cell cultures were performed in triplicate and incubated at 37°C in a humidified atmosphere of 5% carbon dioxide for 4, 5, 6, and 7 days. After culture, plates were pulsed with 1 µCi of [3H]thymidine (Amersham Biosciences Corp, Piscataway, NJ) per well and incubated again at 37°C for 24 hours.
Radiolabeled cells were harvested with a Tomtec Harvester 96 (Tomtec Inc, Hamden, Conn) onto glass filtermats (Wallac Oy, Turku, Finland), and scintillator sheets (Wallac Oy) were melted onto the filtermats. Responder cell proliferation was measured as counts per minute (CPM) on a scintillation counter (Perkin Elmer, Wellesley, Mass). The greatest daily mean proliferation during the 4 days of culture represents the maximum proliferation of each MLR pair. The day when the highest proliferation was observed was considered the day on which the maximum response occurred.
Statistical Analysis
Continuous data are expressed as mean ± SEM. Means of multiple groups were compared by 1-way analysis of variance with Scheffé post hoc analysis to compare individual groups by using SPSS 13.0 (SPSS Inc, Chicago, Ill). The funding organizations assumed no role in data collection, analysis, interpretation, or the right to approve or disapprove publication of the final article.
| Results |
|---|
|
|
|---|
|
Analysis of variance of the proliferative responses of experimental and control groups was performed (P < .001; Figure 2). Scheffé post hoc analysis demonstrated that proliferative responses of the strong responder pairs (53,934 ± 3351 CPM) were significantly greater than the response of either stimulator cells alone (648 ± 92 CPM; P = .002) and responder cells alone (6731 ± 1987 CPM; P = .011). No statistically significant difference in response was identified between the weak allogeneic group (2640 ± 305 CPM) and each negative control group (P = .999 for responder cells alone and P > 0.999 for stimulator cells alone). Concanavalin Atreated responder cells had a significantly higher proliferation than any of the other groups (263,197 ± 30,252 CPM; P
.001 for all groups), as expected. Concanavalin A cross-links cell-surface receptors and generates a nonspecific response that is more intense than the allogeneic response. Responder cells treated with concanavalin A are used as a positive control to ensure their viability and proliferative capability.
|
|
| Discussion |
|---|
|
|
|---|
Results from our study suggest that more than one third of randomly chosen sheep from a single farm maintaining excellent breeding practices may be too closely related to mount an immune response against recipient tissue. Even within the group of strong responders, a wide variation of proliferative response was observed, and only a few MLR pairs showed a very strong response. This finding may reflect a loss of variability of MHC polymorphisms between animals as a result of inbreeding.
In our study, 5 of 14 animals mounted a strong allogeneic response to all stimulators when the responder cells were exposed to 7 or more stimulator cells (Figure 3). It is unlikely that these responder cells were responding to exogenous factors, because cultures from these animals were prepared on different days. Responder cells may proliferate in response to the serum used in the culture medium. However, only 1 of the 8 homogeneous responders demonstrated a high proliferation when cultured alone. No responder cells demonstrated a uniformly weak allogeneic response. Animals such as these that mount a uniformly strong allogeneic response are the ideal donor animals for allogeneic transplant studies.
Understanding the degree of allogenicity of experimental animals is fundamental to the correct interpretation of results from transplant models based on allogeneic animals when inbred strains are not available. To minimize costs, farm sheep, as with many other large animals, may be bred from a limited number of rams, thereby increasing a flock's inbreeding coefficient. This practice increases the probability of randomly selecting related animals for transplantation. Donor and recipient animals that are considered allogeneic may therefore be syngeneic to some degree; this will reduce the recipient's immune response against the donor tissue. In this situation, a reduced alloimmune response may be falsely attributed to the treatment, when in fact the perceived result is simply a factor of the immunologic similarity between the donor and recipient. When assessing the immune response in large animal transplant models, it is critical to assess the level of allogenicity between donor and recipient animals to correctly interpret the results.
Rotational breeding with partially isolated sire lines effectively reduces inbreeding of commercial female animals and their offspring. Migration between lines may inflate the inbreeding of the females, although maintaining 4 to 5 sire lines may minimize this inflation.18
This study clearly demonstrates that even breeding farm sheep with a rotational breeding strategy gives rise to a 37% probability that 2 allogeneic sheep randomly chosen for transplantation are too closely related to elicit an in vitro immune response. These results further demonstrate the importance of assessing allogenicity before performing transplantation studies.
Several reasons may exist for the inflated level of inbreeding within our flock of sheep. Our supplier of sheep maintains 3 breeding lines of rams, whereas 4 or 5 sire lines are required to minimize inbreeding.18
However, by rotating rams off the farm over a 3-year period, our supplier can potentially reduce the coefficient of inbreeding within his flocks of sheep. The effectiveness of this practice to reduce inbreeding, however, is dependent on the genetic dissimilarity of the immigrating rams with the existing flock. Given that sheep are not an endogenous species in Alberta, it is possible that the entire population of sheep in Alberta arose from a limited number of animals and that the flocks in Alberta are relatively closed, thus further increasing the inbreeding coefficient. The estimated inbreeding coefficient in some closed herds may be as high as 0.514.19
The MHC of vertebrates is a group of cell-surface glycoproteins encoded by a group of closely linked, highly polymorphic genes. This bichain complex binds and presents antigenic peptides to T cells. Whereas the MHC is relatively conserved across mammalian species,20
the ovine lymphocyte antigen has yet to be well characterized. Indeed, controversy remains regarding whether 2 or 3 loci encode ovine class I genes.21,22
Inbreeding may reduce the number of MHC polymorphisms, thereby increasing the probability that foreign recipient tissue will be seen as self, thus attenuating the allogeneic immune response.23
A variety of methods for MHC typing have been developed, including serologic testing24
and DNA genotyping. Despite the incomplete characterization of the ovine MHC, some authors have been successful at assessing MHC variation in sheep by using DNA genotyping, include polymerase chain reaction/restriction fragment length polymorphism25
and sequence-specific primer/polymerase chain reaction.26
In vivo and in vitro functional methods are described to assess allogenicity between animals. Split-thickness skin grafts are an excellent in vivo method to assess functional allogenicity, but this method immunologically contaminates the recipient against further studies.
Given the relative importance of the sheep model for cardiovascular immunology research, it may be valuable to develop inbred strains of allogeneic sheep. Such inbred strains would allow further assessment of the immunology of allograft heart valves in a large-animal model. Unfortunately, developing such strains requires a long time commitment, because a minimum of 20 generations of inbreeding would likely be required. It may therefore require more than 20 years of work to develop such strains.19
Ideally, several lines of inbred sheep would be available.
In conclusion, we found that more than one third of sheep purchased from a farm using husbandry practices to reduce inbreeding were likely too closely related to elicit a response on an MLR assay. This study demonstrates the importance of determining the degree of allogenicity of sheep in transplantation studies that use allogeneic sheep models. Other methods of measuring allogenicity are available and include serotyping and genotyping. At a minimum, donor and recipient animals should be purchased from separate farms that do not share breeding animals. Well-characterized inbred strains of sheep may be ideal for such studies, although reduced ovine leukocyte antigen polymorphisms may make these animals prone to infection, and they may be less representative of the human clinical setting, in which donors and recipients are outbred and have a diverse repertoire of HLA polymorphisms.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 Dr Lehr is a Canadian Institutes of Health Research Strategic Training Fellow in TORCH (Tomorrow's Research Cardiovascular Health Professionals). ![]()
2 Dr Rayat is a Canadian Diabetes Association Scholar ![]()
3 Dr Korbutt is an Alberta Heritage Foundation for Medical Research Senior Scholar. ![]()
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |